{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T04:14:54Z","timestamp":1793333694622,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T00:00:00Z","timestamp":1674432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T00:00:00Z","timestamp":1674432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81801203"],"award-info":[{"award-number":["81801203"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Hunan Academician Expert Workstation (Shi Xuemin) Open-end Fund Project","award":["2019YSZJJ12"],"award-info":[{"award-number":["2019YSZJJ12"]}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of\u00a0Hunan Province","doi-asserted-by":"publisher","award":["2022JJ40724"],"award-info":[{"award-number":["2022JJ40724"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science and Technology Innovation Guidance Project of Hunan Province","award":["2020SK53009"],"award-info":[{"award-number":["2020SK53009"]}]},{"name":"Changsha Municipal Natural Science Foundation","award":["kq2007037"],"award-info":[{"award-number":["kq2007037"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s10072-023-06629-8","type":"journal-article","created":{"date-parts":[[2023,1,22]],"date-time":"2023-01-22T22:02:45Z","timestamp":1674424965000},"page":"1739-1747","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Analysis of LAP+ and GARP+ Treg subsets in peripheral blood of patients with neuromyelitis optica spectrum disorders"],"prefix":"10.1007","volume":"44","author":[{"given":"Haobing","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongliang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weifan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuming","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8690-2544","authenticated-orcid":false,"given":"Huan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,23]]},"reference":[{"issue":"9451","key":"6629_CR1","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","volume":"364","author":"VA Lennon","year":"2004","unstructured":"Lennon VA et al (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. The Lancet 364(9451):2106\u20132112","journal-title":"The Lancet"},{"key":"6629_CR2","doi-asserted-by":"crossref","unstructured":"Wingerchuk D et al (2015) International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85(2):177\u2013189","DOI":"10.1212\/WNL.0000000000001729"},{"key":"6629_CR3","doi-asserted-by":"crossref","unstructured":"Fujihara K et al (2020) Interleukin-6 in neuromyelitis optica spectrum disorder pathophysiology. Neurol (R) Neuroimmunol Neuroinflammation 7(5):e841","DOI":"10.1212\/NXI.0000000000000841"},{"issue":"6","key":"6629_CR4","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S1474-4422(12)70133-3","volume":"11","author":"MC Papadopoulos","year":"2012","unstructured":"Papadopoulos MC, Verkman AS (2012) Aquaporin 4 and neuromyelitis optica. Lancet Neurol 11(6):535\u2013544","journal-title":"Lancet Neurol"},{"issue":"1","key":"6629_CR5","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12974-021-02249-1","volume":"18","author":"E CarneroContentti","year":"2021","unstructured":"CarneroContentti E, Correale J (2021) Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategies. J Neuroinflammation 18(1):208","journal-title":"J Neuroinflammation"},{"key":"6629_CR6","doi-asserted-by":"publisher","first-page":"105793","DOI":"10.1016\/j.intimp.2019.105793","volume":"75","author":"M Hou","year":"2019","unstructured":"Hou M et al (2019) Proportions of Th17 cells and Th17-related cytokines in neuromyelitis optica spectrum disorders patients: a meta-analysis. Int Immunopharmacol 75:105793","journal-title":"Int Immunopharmacol"},{"key":"6629_CR7","doi-asserted-by":"crossref","unstructured":"Nicolas P et al (2019) The balance in T follicular helper cell subsets is altered in neuromyelitis optica spectrum disorder patients and restored by rituximab. Front Immunol 10:2686","DOI":"10.3389\/fimmu.2019.02686"},{"issue":"5","key":"6629_CR8","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","volume":"133","author":"S Sakaguchi","year":"2008","unstructured":"Sakaguchi S et al (2008) Regulatory T cells and immune tolerance. Cell 133(5):775\u2013787","journal-title":"Cell"},{"key":"6629_CR9","doi-asserted-by":"publisher","first-page":"378","DOI":"10.3389\/fimmu.2013.00378","volume":"4","author":"M Caridade","year":"2013","unstructured":"Caridade M, Graca L, Ribeiro RM (2013) Mechanisms underlying CD4+ Treg immune regulation in the adult: from experiments to models. Front Immunol 4:378","journal-title":"Front Immunol"},{"issue":"4","key":"6629_CR10","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/ni904","volume":"4","author":"JD Fontenot","year":"2003","unstructured":"Fontenot JD, Gavin MA, Rudensky AY (2003) Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4(4):330\u2013336","journal-title":"Nat Immunol"},{"issue":"5609","key":"6629_CR11","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1126\/science.1079490","volume":"299","author":"S Hori","year":"2003","unstructured":"Hori S, Nomura T, Sakaguchi S (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299(5609):1057\u20131061","journal-title":"Science"},{"issue":"7","key":"6629_CR12","doi-asserted-by":"publisher","first-page":"3433","DOI":"10.4049\/jimmunol.0904028","volume":"184","author":"AM Thornton","year":"2010","unstructured":"Thornton AM et al (2010) Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells. J Immunol 184(7):3433\u20133441","journal-title":"J Immunol"},{"issue":"7\u20138","key":"6629_CR13","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1016\/j.molimm.2010.02.001","volume":"47","author":"D Getnet","year":"2010","unstructured":"Getnet D et al (2010) A role for the transcription factor Helios in human CD4(+)CD25(+) regulatory T cells. Mol Immunol 47(7\u20138):1595\u20131600","journal-title":"Mol Immunol"},{"issue":"6","key":"6629_CR14","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1002\/art.39091","volume":"67","author":"H Takatori","year":"2015","unstructured":"Takatori H et al (2015) Helios enhances Treg cell function in cooperation with FoxP3. Arthritis Rheumatol 67(6):1491\u20131502","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"6629_CR15","first-page":"139","volume":"11","author":"S Assadiasl","year":"2014","unstructured":"Assadiasl S et al (2014) Regulatory T cell subtypes and TGF-\u03b21 gene expression in chronic allograft dysfunction. Iran J Immunol\u202f: IJI 11(3):139\u2013152","journal-title":"Iran J Immunol : IJI"},{"key":"6629_CR16","doi-asserted-by":"publisher","first-page":"104635","DOI":"10.1016\/j.cellimm.2022.104635","volume":"382","author":"A Aguinaga-Barrilero","year":"2022","unstructured":"Aguinaga-Barrilero A et al (2022) Higher prevalence of LAP+ (Latency TGFbeta-Associated Peptide) T cells at the tissue level in patients with early gastric cancer. Cell Immunol 382:104635","journal-title":"Cell Immunol"},{"key":"6629_CR17","doi-asserted-by":"publisher","first-page":"3343","DOI":"10.1111\/j.1582-4934.2009.00782.x","volume":"13","author":"M Probst-Kepper","year":"2009","unstructured":"Probst-Kepper M et al (2009) GARP: a key receptor controlling FOXP3 in human regulatory T cells. J Cell Mol Med 13:3343\u20133357","journal-title":"J Cell Mol Med"},{"issue":"7","key":"6629_CR18","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1038\/s41423-021-00701-z","volume":"18","author":"P Lehmkuhl","year":"2021","unstructured":"Lehmkuhl P et al (2021) Dysregulated immunity in PID patients with low GARP expression on Tregs due to mutations in LRRC32. Cell Mol Immunol 18(7):1677\u20131691","journal-title":"Cell Mol Immunol"},{"issue":"8","key":"6629_CR19","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1093\/intimm\/dxab027","volume":"33","author":"K Satoh","year":"2021","unstructured":"Satoh K et al (2021) Novel anti-GARP antibody DS-1055a augments anti-tumor immunity by depleting highly suppressive GARP+ regulatory T cells. Int Immunol 33(8):435\u2013446","journal-title":"Int Immunol"},{"issue":"9","key":"6629_CR20","doi-asserted-by":"publisher","first-page":"4620","DOI":"10.4049\/jimmunol.0903329","volume":"184","author":"R Gandhi","year":"2010","unstructured":"Gandhi R et al (2010) Cutting edge: human latency-associated peptide+ T cells: a novel regulatory T cell subset. J Immunol 184(9):4620\u20134624","journal-title":"J Immunol"},{"key":"6629_CR21","doi-asserted-by":"crossref","unstructured":"Shi F et al (1999) Mechanisms of nasal tolerance induction in experimental autoimmune myasthenia gravis: identification of regulatory cells. J Immunol (Baltimore, Md. 1950) 162(10):5757\u201363","DOI":"10.4049\/jimmunol.162.10.5757"},{"issue":"9","key":"6629_CR22","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1136\/annrheumdis-2012-202216","volume":"72","author":"T Alexander","year":"2013","unstructured":"Alexander T et al (2013) Foxp3+ Helios+ regulatory T cells are expanded in active systemic lupus erythematosus. Ann Rheum Dis 72(9):1549\u20131558","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"6629_CR23","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.4049\/jimmunol.170.5.2516","volume":"170","author":"T Oida","year":"2003","unstructured":"Oida T et al (2003) CD4+CD25- T cells that express latency-associated peptide on the surface suppress CD4+CD45RBhigh-induced colitis by a TGF-beta-dependent mechanism. J Immunol 170(5):2516\u20132522","journal-title":"J Immunol"},{"issue":"3","key":"6629_CR24","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/j.1365-2249.2006.03271.x","volume":"147","author":"U Feger","year":"2007","unstructured":"Feger U et al (2007) Increased frequency of CD4+ CD25+ regulatory T cells in the cerebrospinal fluid but not in the blood of multiple sclerosis patients. Clin Exp Immunol 147(3):412\u2013418","journal-title":"Clin Exp Immunol"},{"issue":"7","key":"6629_CR25","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1084\/jem.20031579","volume":"199","author":"V Viglietta","year":"2004","unstructured":"Viglietta V et al (2004) Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med 199(7):971\u2013979","journal-title":"J Exp Med"},{"issue":"2","key":"6629_CR26","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1158\/2159-8290.CD-12-0010","volume":"2","author":"SM Lee","year":"2012","unstructured":"Lee SM, Yee C (2012) Another LAP in the race. Cancer Discov 2(2):107\u2013109","journal-title":"Cancer Discov"},{"issue":"32","key":"6629_CR27","doi-asserted-by":"publisher","first-page":"13439","DOI":"10.1073\/pnas.0901965106","volume":"106","author":"R Wang","year":"2009","unstructured":"Wang R et al (2009) Expression of GARP selectively identifies activated human FOXP3+ regulatory T cells. Proc Natl Acad Sci USA 106(32):13439\u201313444","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"6629_CR28","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/pedi.12029","volume":"14","author":"N Marek-Trzonkowska","year":"2013","unstructured":"Marek-Trzonkowska N et al (2013) Clinical application of regulatory T cells in type 1 diabetes. Pediatr Diabetes 14(5):322\u2013332","journal-title":"Pediatr Diabetes"},{"key":"6629_CR29","doi-asserted-by":"crossref","unstructured":"Bluestone J et al (2015) Type 1 diabetes immunotherapy using polyclonal regulatory T cells. Sci Transl Med 7(315):315ra189","DOI":"10.1126\/scitranslmed.aad4134"},{"issue":"2","key":"6629_CR30","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.nbd.2004.03.017","volume":"16","author":"RS Duan","year":"2004","unstructured":"Duan RS et al (2004) Protective potential of experimental autoimmune myasthenia gravis in Lewis rats by IL-10-modified dendritic cells. Neurobiol Dis 16(2):461\u2013467","journal-title":"Neurobiol Dis"},{"issue":"12","key":"6629_CR31","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1177\/1352458510379247","volume":"16","author":"A Uzawa","year":"2010","unstructured":"Uzawa A et al (2010) Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6. Mult Scler 16(12):1443\u20131452","journal-title":"Mult Scler"},{"issue":"20","key":"6629_CR32","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1212\/WNL.0b013e3181c1deb9","volume":"73","author":"K Yanagawa","year":"2009","unstructured":"Yanagawa K et al (2009) Pathologic and immunologic profiles of a limited form of neuromyelitis optica with myelitis. Neurology 73(20):1628\u20131637","journal-title":"Neurology"},{"key":"6629_CR33","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1196\/annals.1321.009","volume":"1024","author":"D Franchimont","year":"2004","unstructured":"Franchimont D (2004) Overview of the actions of glucocorticoids on the immune response: a good model to characterize new pathways of immunosuppression for new treatment strategies. Ann N Y Acad Sci 1024:124\u2013137","journal-title":"Ann N Y Acad Sci"},{"issue":"11","key":"6629_CR34","doi-asserted-by":"publisher","first-page":"7327","DOI":"10.4049\/jimmunol.180.11.7327","volume":"180","author":"ML Chen","year":"2008","unstructured":"Chen ML et al (2008) Latency-associated peptide identifies a novel CD4+CD25+ regulatory T cell subset with TGFbeta-mediated function and enhanced suppression of experimental autoimmune encephalomyelitis. J Immunol 180(11):7327\u20137337","journal-title":"J Immunol"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-023-06629-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-023-06629-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-023-06629-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T20:07:34Z","timestamp":1681416454000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-023-06629-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,23]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["6629"],"URL":"https:\/\/doi.org\/10.1007\/s10072-023-06629-8","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,23]]},"assertion":[{"value":"3 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures involving human participants were approved by the Medical Ethics Committee of Xiangya Hospital of Central South University (NO.201904147).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}